NetScientific is a transatlantic healthcare IP commercialisation group.
Our Portfolio
Targeting chronic diseases
OUR TEAM
Sector-specialist senior management team with extensive commercial experience.
Sir Richard Sykes, FRS
Sir Richard Sykes, Non-Executive Chairman of the Group, joined NetScientific in 2008. Sir Richard spent thirty years working in the biotechnology and pharmaceutical industries, …
ChairmanIan Postlethwaite
Ian Postlethwaite, Chief Executive Office, Chief Financial Officer & Company Secretary, joined NetScientific in June 2016. He brings over 14 years of biopharma experience …
Chief Executive Officer, Chief Financial Officer & Company Secretary
NEWS
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology equity issue and related party transaction London, UK – 12 February 2020: NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP …
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology proposed offering London, UK – 11 February 2020: NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation group, announces …
NetScientific plc (“NetScientific” or the “Company”) Board Change Resignation of Ian Postlethwaite as CEO, CFO and Company Secretary London, UK – 15 January 2020: NetScientific plc (AIM: NSCI), …
NetScientific plc
PO Box 597
Ashford
TN23 9XX
Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net
copyright
NetScientific healthcare technology group